Abstract: Embodiments of the present disclosure related to systems and methods of determining, computing, or simulating crop yield for a growing season. In certain embodiments, the model begins with a yield potential reflective of environmental limitations for a particular field which assumes that the grower has chosen a crop variety that is appropriate for their growing season and has managed their farm optimally. An end-of-season yield is predicted by accounting for environmental stressors, which are applied to the starting yield potential as penalties, in certain embodiments, the crop yield model simulates post-, in-, and end-of-season yield potentials by classifying major categories of plant stressors. These stressors are used to track and penalize yield potential using a dynamic set of inputs. The crop yield model works in conjunction with a crop phenology model to facilitate identification of historical averages for various phenological states of the crop development.

Abstract: Embodiments of the present disclosure related to systems and methods of a field-scale crop phenology model for simulating/computing plant development stages of a crop. The field-scale crop phenology model is used to simulate plant development stages during a growing season. Knowledge of plant stages, especially as a forecast, helps the timing of chemical applications as well as other crop-dependent management decisions. Together with a user's field location, planting date, and varietal information, the crop phenology model serves as a robust field-scale decision-making tool. In certain embodiments, the phenology model can be run under three different scenarios: historical, preseason, or in-season. Using a blend of different weather data inputs, the phenology model can generate phenology results based on the desired scenario of a user.

Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.

Abstract: The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.